Case Studies

Oncology adherence program

Challenge

Clinical trials showed a 50% discontinuation of treatment within the first 8 weeks of therapy. This was due to several challenges: difficulty staying adherent to 2x daily oral oncolytic, older age of the patient population, and side effects.

Solution

Develop a patient community to seamlessly onboard patients to their oral oncolytic, provide educational content and insights to address their questions, and connect them with peers & community managers to leave ‘no patient alone’

- AI matched patients for peer mentorship
- Proactively educate on side effects
- Push notifications for medication adherence & tracking
- PSP connectivity cross-validated patient status
- PSP ID used as gating mechanism

A phone screen showing Oncology user app

Results

86% of patients in app monthly
71% of patients stayed on therapy past 8-week checkpoint
73% of patients said the app helped them better manage and report side effects
70% of patients digested 4 educational health programs

Go to Next Study